Tuohan on ainut tapa jos ne meinaa tästä loppuporukasta saada ketään piikille rokotuskattavuuden noston toivossa. Novavaxia ilmeisesti tarvis 2 mut luin, että valnevaa riittäs 1? Ootko löytäny mitää tietoa tosta? Tietysti en ota kumpaakaan, mut jos menee niin pitkälle ettei olis vaihtoehtoja
Phase 3ssa oli pfizer+ novavax kombo mukana tutkimus asetelmassa. Eli uskosin että 1.pfizer ja 1 novavax ois oikein bueno. Valmistetaan eteläkoreassa tällä hetkellä. Pääasiassa on ilmeisesti 2. annoksen juttu.
Pitää kaivaa valnevasta tietoo kun tuun salilta.
Ainakin tutkittu jenkeissä, briteissä ja meksikossa eteläafrikassa. Sen lisäks käytössä ilmeisesti indonesiassa.
The two-dose vaccine, which is easier to transport and store than other shots, could play an important role in increasing supplies in developing countries.
www.nbcnews.com
ELi dataa on käsittääkseni vuoden käyttöajalta. SÄilyy myöskin jääkaappi lämmössä 3kk.
Vaccine Timeline
January, 2020 Novavax begins work on a coronavirus vaccine.
A screen showing protein structures at a Novavax lab in Maryland.Andrew Caballero-Reynolds/Agence France-Presse
May Novavax launches clinical trials for their vaccine.
July The U.S. government awards Novavax
$1.6 billion to support the vaccine’s clinical trials and manufacturing.
August Novavax launched a
Phase 2 trial on 2,900 people in South Africa.
Preparing an injection in Johannesburg, South Africa.Joao Silva/The New York Times
September Novavax
launches a
Phase 3 trial with up to 15,000 volunteers in the United Kingdom. The trial is expected to
deliver results in early 2021.
Dec. 28 Novavax launches a
Phase 3 trial with 30,000 people in the United States. The trial had been delayed because of problems with manufacturing the doses required for the study.
March 11, 2021 Novavax
reported that their United Kingdom trial determined an efficacy rate of 96 percent against the original coronavirus. But in South Africa, where volunteers were exposed to the variant B.1.351, the efficacy was only 49 percent. The company is developing a new version of the vaccine that is tailored to that variant.
April 13 Novavax
says it could reach its production goal of 150 million doses per month by the third quarter of 2021.
May 3 Novavax expands its U.S. Phase 3 trial to include
volunteers as young as 12.
Sources: National Center for Biotechnology Information; Nature Reviews Immunology; Science; Maria Elena Bottazzi, Baylor College of Medicine; Matthew Frieman, University of Maryland School of Medicine.
Learn about viruses and diseases from Novavax. Explore our resources about the causes and vaccines related to different diseases and illnesses.
www.novavax.com
laittakaa ne Alkot kiinni ku siihenki kuolee enempi 
